We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PHC Plant Health Care Plc

0.00 (0.00%)
Last Updated: 08:00:11
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.78 3.70 4.16 - 0.00 08:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -1.36 12.91M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.78p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 11.60p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £12.91 million. Plant Health Care has a price to earnings ratio (PE ratio) of -1.36.

Plant Health Care Share Discussion Threads

Showing 551 to 575 of 1350 messages
Chat Pages: Latest  30  29  28  27  26  25  24  23  22  21  20  19  Older
With PHC's commercial business now on a firm growth track (on track for a 30% increase over 2017) and with the PREtec technology platform still generating positive results and 'continued' interest, I think it's likely that some form of technology development agreement could be entered into. If this came to fruition, and depending on the percentage of the R&D the partner was responsible for, this could fast track PHC toward break-even/profitability (R&D in 2017 was $5.1 million).

The following comment from the Trading Statement is perhaps indicative -

"Outside Brazil, our partners continue to generate positive results with PREtec peptides. While the specific results remain confidential at this stage, partners are seeking to expand their evaluations and build closer relationships with Plant Health Care."

Harpin alone likely covers the current market cap.
The IP is where the value is maybe not right now but a few years down the line.They also have many years of data so any price above and beyond what RG paid for the placing /buyout shares looks a good place to start all IMHO of course.
Without soyabean success what's it worth???
I think there is some value here for one of the big six (soon to be 5 )and with RG in control with his large holding it wouldn't be a great shock to see them bought out.No real reason to invest here as that could be many months away and by their own conviction don't expect any licenses to be sold soon.
A mixed bag!

A disappointment in ASR, but I still believe the peptide approach will result in benefits to agriculture, indeed as indicated. Importantly, the yield results continue to generate interest from the large players, not to mention supportive scientific evidence.

Off-setting the disappointment is that significant growth in revenues will be realised, with further growth forecast going forwards.

Jam tomorrow - increasing yields on sugar cane as sugar prices are falling??
Well unfortunately yet again more delays so consider the can being kicked.
Recall that PHC's PREtec technology platforms ultimately regulate the genes in plants.

Readers will note the reference to gene regulation in the following article. The company ultimately being interviewed is a large player in the US;

Weeding Out the Noise in the Biostimulant Space

6th June 2018

"If we can use a product to upregulate or downregulate some genes, that’s something we’re starting to look at with a number of suppliers. We can track how we’re affecting a plant’s genetic expression. These are all in the R&D phase now. Things have certainly been ramped up in the last few years, which I think is good. That’s the natural evolution of things. We can see some yield and quality responses, but I don’t know if we can tell you why they did what they did. Now, we’re really starting to dive in to figuring out the ‘whys,’ especially with the next-generation products."

"We’re looking at newer products that trigger, or upregulate or downregulate a gene within a plant. So that’s kind of the frontier."

"I do see some real promising things on the frontier with companies using available technology to show activation of a gene within a plant, salt tolerance, and things like that. This is real and relevant within our space. I’m glad to see things moving in a more scientific direction."

Full article

There has been (and still is) a lot of interesting reports and activity on PHC's twitter feed. The teams appear to be 'very' ProAct®ive on different continents ;-)
Funding again???
Wan agreed, but Mr Market has an uncanny knack of being right more often than not - As we know too well to our cost from PIM (amongst many others) - Have a great week.
Pugugly...Not everything is a sign of bad news!
News leaking ? Perhaps very bad news? As now down 10% today on increasing volume. Down 16.7% over 3 days on constant faller list.
New Market Insights for Crop Biologics
June 13, 2018

American agriculture is undergoing a new wave of productivity and enhanced sustainability. While many previous advances focused on enhancing a plant’s internal ability to overcome natural challenges, this next wave focuses on the critical interactions between plants and the surrounding microbiome. In recent years, there has been a renewed emphasis on improving soil health. This next wave focuses on the interactions between a growing crop and the microbial community in and around the soil. This is an incredibly complex endeavor to identify those microbes that are beneficial in improving yield, increasing nutrient efficiency, improving abiotic stress tolerance or protecting against harmful pests and diseases.

A recently released business study “Plant Microbiome, The Next Wave in Agriculture?,” conducted by BioCognito and Farmgate Insights, takes a multifaceted look at this expanding field of agriculture. Microbial additives or “biologics” are becoming an important approach for farmers looking for ways to manage production challenges.

Companies across the agricultural spectrum are investing heavily in this new wave. Over the past five years, there has been more than $5 billion of disclosed investment in this space. “We have seen multinationals form new alliances, well known crop protection and nutrient companies purchase startups, and an explosion of innovators, all trying to be a part of the action” said Nathan Danielson, one of the report’s authors. “Companies that didn’t exist 5 and 10 years ago are raising ten of millions of dollars, and one has recently attained ‘Unicorn’ status. Meanwhile, traditional agriculture companies are pursuing different strategies such as bundling biologics with a whole suite of products or tying them with existing crop protection and fertilizers.”

While the use of biologics in specialty crops and the organic industry are ahead of row crops, with over 250 million acres planted annually this is a huge potential market. “One of our study goals was to look at the five primary field crops in the U.S. (corn, soybeans, wheat, cotton and sorghum) and analyze their unique barriers to entry and potential delivery systems for biologics,” stated co-author Paul Bertels. “We have talked with a number of growers and commodity organizations to get their perspectives on what do want to enhance adoption.”

In support of the study, the authors have created an interactive cost-benefit model for each crop to help farmers or industry assess the value of a new product. “Our models indicate value creation in excess of $8.5 billion in farmgate revenue for these five crops in the US alone. This value is largely driven by yield increases and the ability to utilize marginal land, however a number of other drivers were important. According to co-author Nathan Danielson “We used conservative assumptions in our models and still saw very significant new value creation. Beyond this, there were specific geographies and market sectors that were really exciting opportunities”.

The reward for capturing market share is enormous. Corn, cotton, soybeans, sorghum and wheat represent a significant opportunity for crop biologics.

The market study “Plant Microbiome: The Next Wave in Agriculture” provides the reader with a clear understanding of the landscape of the market place. This is accomplished through analysis on market structure and barriers to entry as well insights into market participants and those who may enter. Finally, customizable models are provided to readers to allow value determination for specific crops and geographies.

PHC's Brazil Director, Rodrigo de Miranda, will be speaking at the following congress -

Biopesticides and biostimulants / biofertilizers are growing in demand. With Latin America being a world hub for agriculture it is no surprise that these products are seeing rapid growth. Agbio Innovate LATAM is focussed on R&D, regulation and commercialization of biopesticides and biofertilizers/ biostimulants in Latin America, and unites key stakeholders across the globe.

Developing a new generation of products

Moving from the traditional chemical market
to biologicals

Challenges faced and how we managed this

Rodrigo de Miranda, Brazil Director,
Plant Health Care, Brazil

wan - many thanks for link - much appreciated - may explain the sP movement -
PHC Investor Presentation, US , 25th May 2018 -
Recall from my post 17 that Spain is the biggest purveyor of fresh fruits in Europe.

The following PHC presentaion is interesting then and is from the International Symposium on Citrus Biotechnology in April 2018 -

Mobilizing Ca to enhance fruit quality:
Ángel Marín, Plant Health Care S.A. Spain.
K. Staska, A. Dillon.
Application of harpin αβ (ProAct®) in
citrus orchards in Spain

The following provides an insightful read to an existing and growing problem, a very large problem -

Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Matthew C. Fisher1,*, Nichola J. Hawkins2, Dominique Sanglard3, Sarah J. Gurr4,5,*

Science 18 May 2018:

The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonly used antifungal agents is unprecedented. The azoles, for example, are used not only for human and animal health care and crop protection but also in antifouling coatings and timber preservation. The ubiquity and multiple uses of azoles have hastened the independent evolution of resistance in many environments. One consequence is an increasing risk in human health care from naturally occurring opportunistic fungal pathogens that have acquired resistance to this broad class of chemicals. To avoid a global collapse in our ability to control fungal infections and to avoid critical failures in medicine and food security, we must improve our stewardship of extant chemicals, promote new antifungal discovery, and leverage emerging technologies for alternative solutions.

This is why the large players are already interested and trialing various PHC Plant Response Elicitor technology. Excerpt from the Annual Report (page 1) -

All five of the top global agricultural/seed companies and a number of other companies are testing leadpeptides from our PREtec platforms Innatus™ 3G, T-Rex 3G and Y-Max 3G.

• Four global agricultural/seed majors are running field trials in Brazil of Innatus 3G added to chemical sprays for the control of Asian Soybean Rust (ASR), a devastating fungal disease of soybeans. Farmers spent US$1.7 billion on soybean fungicides in 2016 in Brazil; there are increasing concerns about disease resistance and the resulting impact on yield.

• Exclusive rights to Innatus 3G for use in South American soybeans are expected to be licensed through a competitive licensing process in the second half of 2018.
• In the Company’s trials, our lead peptides have shown promise for the control of ASR, especially for the control of resistant disease when used in mixture with conventional agrochemicals. Data from these ASR trials are due in Q2 2018.

• PHC expanded its programme of trials in other crops. Results continued to show good performance for Innatus 3G under disease and drought stress, and for T-Rex 3G against nematodes. Y-Max 3G peptides increased yields even under optimal growing conditions.

• Discussions continue with partners about future licensing of Innatus 3G in other crops and regions and of both T-Rex 3G and Y-Max 3G.

PHC Annual Report -

Dubai...No, but I have spent a number of years reading up and researching the industry, to the extent that I feel that I have built up a reasonable level of knowledge.
WAN were you in the industry at all?
Thanks Pugugly, there are in fact a number of companies breeding and supplying predators as a form of bio-control. I think that approach will remain quite small and niche though.
wan_ A couple of developments out of Africa which may be of interest and point the way to a cleaner and greener food chain for fruit and veg -

Both private and small companies but they seem to be onto something and possibly the technology might eventually have legs -Thoughts?

Using tiny predators to tackle agricultural pests

also website of the other company mentioned in the above news flash -

Following on from my post number 3, where I highlighted a recent and significant scientific discovery as potentially underscoring, if not intensifying, the interest in PHC's new technology, PREtec (peptides that can provide various agronomic benefits for use in agriculture)

The same scientific institution continues to add scientific evidence that PHC are on to something very significant. In my opinion, the following adds further credibility to PHC's technology offerings -

Plant Peptide Spells Relief from Salty Stress
Published: May 14, 2018.
Released by RIKEN

Researchers at the RIKEN Center for Sustainable Resource Science (CSRS) have discovered a hormone-like peptide in plants that helps increase their tolerance to excessive salt. Published in the Proceedings of the National Academy of Sciences USA, the study found several genes that can increase salinity tolerance, the most effective being a small gene that codes for the peptide AT13.

First author Kentaro Nakaminami notes, "We found the first functional evidence for improved salinity stress tolerance in plants in response to treatment with a small peptide. This is a first step towards the production of new agricultural supplements for plants growing in high salinity conditions."

This method has key benefits. "Peptides are natural compounds that are safer than genetically modified plants," says Nakaminami. "Additionally, potential supplements made from synthetic peptide fragments will be easy to apply to different species of plants."

Small coding genes in plants are numerous but have not yet been well documented or researched. Hanada is hopeful that many more peptide hormones in plants will soon be discovered. "We think that plants have many peptide hormones associated with physiological roles," he says. "We strongly believe that analysis of small coding genes or peptide hormones may provide new targets for understanding plant biology and improving crop yields in environmentally stressful conditions."

Full release -

The last two paragraphs are important. Put another way, a key advantage of the peptide approach is that these compounds occur naturally and are bioactive when applied externally. In other words, there are no residues, and importantly no genetic changes need to be introduced into crop species through lengthy breeding programs to achieve desired effects when using peptides.

Chat Pages: Latest  30  29  28  27  26  25  24  23  22  21  20  19  Older

Your Recent History

Delayed Upgrade Clock